Certican

Certican (Everolimus) is an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication helps manage immune responses, ensuring compatibility with transplanted organs.

Certican is primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. It works by suppressing the immune system's response to the new organ, reducing the risk of rejection. Everolimus is often part of a broader treatment plan that includes other immunosuppressants and careful monitoring by healthcare professionals.

Common effects of Certican may include headaches, nausea, and fatigue. Some users also report mild digestive issues or changes in blood pressure. These effects can vary widely depending on individual health factors and the specific transplant procedure.

Certican should be handled with care, as it affects the immune system. Patients should follow their healthcare provider's instructions closely and avoid activities that may increase the risk of infection. Regular blood tests are often recommended to monitor liver function and other health indicators.

Certican may interact with certain medications, including those that affect liver enzymes. Alcohol and other immunosuppressants can also influence its effectiveness. Patients should discuss all current medications with their healthcare provider to avoid potential interactions.